Report Detail

Request for Sample of this report

Pharma & Healthcare Global Peptide Receptor Radionuclide Therapy (PRRT) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3860239
    • |
  • 13 August, 2024
    • |
  • Global
    • |
  • 98 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peptide Receptor Radionuclide Therapy (PRRT) market size was valued at USD 1073.2 million in 2023 and is forecast to a readjusted size of USD 3159.9 million by 2030 with a CAGR of 16.7% during review period.
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Peptide Receptor Radionuclide Therapy (PRRT) industry chain, the market status of Hospital Pharmacies (Gastroenteropancreatic Neuroendocrine Tumor, Foregut Neuroendocrine Tumor), Retail Pharmacies (Gastroenteropancreatic Neuroendocrine Tumor, Foregut Neuroendocrine Tumor), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Peptide Receptor Radionuclide Therapy (PRRT).
Regionally, the report analyzes the Peptide Receptor Radionuclide Therapy (PRRT) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Peptide Receptor Radionuclide Therapy (PRRT) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Peptide Receptor Radionuclide Therapy (PRRT) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Peptide Receptor Radionuclide Therapy (PRRT) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Gastroenteropancreatic Neuroendocrine Tumor, Foregut Neuroendocrine Tumor).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Peptide Receptor Radionuclide Therapy (PRRT) market.
Regional Analysis: The report involves examining the Peptide Receptor Radionuclide Therapy (PRRT) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Peptide Receptor Radionuclide Therapy (PRRT) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Peptide Receptor Radionuclide Therapy (PRRT):
Company Analysis: Report covers individual Peptide Receptor Radionuclide Therapy (PRRT) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Peptide Receptor Radionuclide Therapy (PRRT) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Peptide Receptor Radionuclide Therapy (PRRT). It assesses the current state, advancements, and potential future developments in Peptide Receptor Radionuclide Therapy (PRRT) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Peptide Receptor Radionuclide Therapy (PRRT) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Peptide Receptor Radionuclide Therapy (PRRT) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
Curium Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Peptide Receptor Radionuclide Therapy (PRRT) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Peptide Receptor Radionuclide Therapy (PRRT), with revenue, gross margin and global market share of Peptide Receptor Radionuclide Therapy (PRRT) from 2019 to 2024.
Chapter 3, the Peptide Receptor Radionuclide Therapy (PRRT) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Peptide Receptor Radionuclide Therapy (PRRT) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide Receptor Radionuclide Therapy (PRRT).
Chapter 13, to describe Peptide Receptor Radionuclide Therapy (PRRT) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Peptide Receptor Radionuclide Therapy (PRRT)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Peptide Receptor Radionuclide Therapy (PRRT) by Type
    • 1.3.1 Overview: Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value Market Share by Type in 2023
    • 1.3.3 Gastroenteropancreatic Neuroendocrine Tumor
    • 1.3.4 Foregut Neuroendocrine Tumor
    • 1.3.5 Midgut Neuroendocrine Tumor
    • 1.3.6 Hindgut Neuroendocrine Tumor
  • 1.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market by Application
    • 1.4.1 Overview: Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size & Forecast
  • 1.6 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast by Region
    • 1.6.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region, (2019-2030)
    • 1.6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Prospect (2019-2030)
    • 1.6.6 South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product and Solutions
    • 2.1.4 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product and Solutions
    • 2.2.4 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Lantheus
    • 2.3.1 Lantheus Details
    • 2.3.2 Lantheus Major Business
    • 2.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product and Solutions
    • 2.3.4 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Lantheus Recent Developments and Future Plans
  • 2.4 Aurobindo Pharma
    • 2.4.1 Aurobindo Pharma Details
    • 2.4.2 Aurobindo Pharma Major Business
    • 2.4.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product and Solutions
    • 2.4.4 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Aurobindo Pharma Recent Developments and Future Plans
  • 2.5 Mundipharma
    • 2.5.1 Mundipharma Details
    • 2.5.2 Mundipharma Major Business
    • 2.5.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product and Solutions
    • 2.5.4 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Mundipharma Recent Developments and Future Plans
  • 2.6 Curium Pharmaceuticals
    • 2.6.1 Curium Pharmaceuticals Details
    • 2.6.2 Curium Pharmaceuticals Major Business
    • 2.6.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product and Solutions
    • 2.6.4 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Curium Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Peptide Receptor Radionuclide Therapy (PRRT) by Company Revenue
    • 3.2.2 Top 3 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share in 2023
    • 3.2.3 Top 6 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share in 2023
  • 3.3 Peptide Receptor Radionuclide Therapy (PRRT) Market: Overall Company Footprint Analysis
    • 3.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market: Region Footprint
    • 3.3.2 Peptide Receptor Radionuclide Therapy (PRRT) Market: Company Product Type Footprint
    • 3.3.3 Peptide Receptor Radionuclide Therapy (PRRT) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Type (2019-2030)
  • 6.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Application (2019-2030)
  • 6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
    • 6.3.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Country (2019-2030)
    • 6.3.2 United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Type (2019-2030)
  • 7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Application (2019-2030)
  • 7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
    • 7.3.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 7.3.3 France Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region
    • 8.3.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Region (2019-2030)
    • 8.3.2 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 8.3.5 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Type (2019-2030)
  • 9.2 South America Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Application (2019-2030)
  • 9.3 South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
    • 9.3.1 South America Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
    • 10.3.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers
  • 11.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints
  • 11.3 Peptide Receptor Radionuclide Therapy (PRRT) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Peptide Receptor Radionuclide Therapy (PRRT) Industry Chain
  • 12.2 Peptide Receptor Radionuclide Therapy (PRRT) Upstream Analysis
  • 12.3 Peptide Receptor Radionuclide Therapy (PRRT) Midstream Analysis
  • 12.4 Peptide Receptor Radionuclide Therapy (PRRT) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Peptide Receptor Radionuclide Therapy (PRRT). Industry analysis & Market Report on Peptide Receptor Radionuclide Therapy (PRRT) is a syndicated market report, published as Global Peptide Receptor Radionuclide Therapy (PRRT) Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Peptide Receptor Radionuclide Therapy (PRRT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo